HSE Vitamin D: What to Know About Sources, Use and Safety

What does the HSE recommend for vitamin D?

HSE advice in Ireland, by population group

The HSE vitamin D guidance splits advice by age and by whether someone is likely to make less vitamin D from sunlight in Ireland. For labels, the simple conversion is 1 microgram (µg) = 40 International Units (IU).

Why some HSE advice is seasonal and some is year-round

The HSE says that in Ireland sunlight is not strong enough between October and early March for the skin to make vitamin D, which is why the public advice uses a winter window from Halloween to St Patrick's Day. The same HSE page advises year-round supplements for groups with less effective sun-derived production or less sun exposure, including people with darker skin tone, people who stay indoors or cover up, pregnant women, adults aged 65+ and babies.

Label check: 5 µg = 200 IU, 10 µg = 400 IU, 15 µg = 600 IU.

How HSE compares with EFSA, SACN and NIH

At European level, EFSA set an adequate intake of 15 µg (600 IU) a day for healthy people over 1 year, including pregnant and lactating women, and 10 µg (400 IU) for infants aged 7-11 months. EFSA states that these values are based on an assumption of minimal cutaneous vitamin D synthesis, and that when skin synthesis is present, the dietary requirement is lower or may even be zero.

The UK Scientific Advisory Committee on Nutrition (SACN) value cited by EFSA is 10 µg (400 IU) a day for people aged 4 years and over. In the United States, the NIH Office of Dietary Supplements lists 10 µg (400 IU) for infants 0-12 months, 15 µg (600 IU) for ages 1-70 years including pregnancy and lactation, and 20 µg (800 IU) for adults over 70.

Those numbers do not match perfectly because they are not all the same type of advice. HSE guidance is a practical Ireland-specific schedule built around winter sunlight and higher-risk groups, while EFSA DRVs and NIH reference values are reference intakes set under stated assumptions, including low or minimal sun exposure. That is also why the separate HSE pregnancy guideline uses 10 µg (400 IU), while EFSA and NIH both use 15 µg (600 IU) for pregnancy, and EFSA also uses 15 µg for lactation.

Why does vitamin D matter for bones, muscles and immunity?

From UV-B or food to the form doctors measure

Vitamin D reaches the body in two main ways: vitamin D3 can be made in skin after exposure to UV-B light, while vitamin D2 and D3 are also present in foods and supplements. EFSA notes that, when UV-B exposure is low, dietary vitamin D becomes essential. It also describes vitamin D as a prohormone, because it needs two activation steps before it becomes biologically active. The first step happens in the liver, where vitamin D is converted to 25-hydroxyvitamin D, or 25(OH)D; the second happens primarily in the kidneys, where 25(OH)D is converted to 1,25(OH)2D, the active hormonal form. EFSA says 25(OH)D is the major circulating form, has a half-life of about 13 to 15 days, and reflects vitamin D from both skin and diet, which is why it is used as the main marker of status. EFSA scientific opinion on dietary reference values for vitamin D

Bone health depends on calcium, phosphorus and enough vitamin D

The active form, 1,25(OH)2D, helps maintain calcium and phosphorus homeostasis. EFSA says vitamin D deficiency impairs bone mineralisation because dietary calcium and phosphorus are absorbed inefficiently, with rickets in children and osteomalacia in adults as the clinical consequences. When EFSA set reference values for Europe, it judged a serum 25(OH)D concentration of 50 nmol/L to be a suitable target value for all population groups and found increased risk of adverse musculoskeletal outcomes below that level. EFSA scientific opinion on dietary reference values for vitamin D

Muscles and falls: the practical reason low status matters

EFSA’s public summary says vitamin D helps maintain normal bones and muscle function. That is an important distinction: vitamin D is linked to muscle function through deficiency risk, not as a shortcut around strength training, protein intake or broader fall-prevention measures. EFSA vitamin D reference values summary EFSA scientific opinion on dietary reference values for vitamin D

What is established for immunity, and where calcium still comes first

Mainstream nutrition references are more cautious on immunity than many headlines are. The NIH Office of Dietary Supplements says vitamin D is important for immune function, but it also notes that evidence on respiratory infections is mixed and any reduction in risk may be slight, especially in people with low baseline levels. For readers, the useful takeaway is that vitamin D has an established place in normal immune function, while bigger claims about infection outcomes go beyond firm evidence. NIH Office of Dietary Supplements immune function fact sheet

Vitamin D and calcium work together, not interchangeably. EFSA states that its vitamin D reference values are set on the assumption that interacting nutrients such as calcium are adequate. In practice, vitamin D can help the body absorb and handle calcium, but it cannot make up for a chronically low-calcium diet. EFSA scientific opinion on dietary reference values for vitamin D

Can sunlight in Ireland give you enough vitamin D?

Your skin makes vitamin D when ultraviolet-B light reaches it: EFSA describes vitamin D3 as being synthesised endogenously in the skin after exposure to UV-B irradiation. In Ireland, the HSE says that from October to early March, sunlight is not strong enough to generate vitamin D in the skin, so winter sunshine is not a dependable source. EFSA scientific opinion on vitamin D and UV-B HSE vitamin D guidance for Ireland

Why Ireland’s winter light often falls short

EFSA lists latitude and season among the factors that affect skin production, and it also notes that clouds absorb UV-B. In practical Irish terms, that means the darker months, overcast days, and time spent mostly indoors all push production down before diet even enters the picture. EFSA scientific opinion on factors affecting skin synthesis

A common mistake is to overestimate bright indoor light. EFSA names time spent outdoors as one of the variables that changes how much vitamin D the skin can make, and the HSE lists people who are housebound or living in nursing homes among the groups who should not rely on sunlight alone all year. EFSA on time outdoors and skin synthesis HSE list of year-round risk groups

Who makes less from the same sun?

Why a sunny holiday is not a year’s insurance policy

EFSA says sun exposure can contribute a considerable and varying amount of vitamin D, but it varies with clouds, time spent outdoors, sunscreen use, clothing, skin colour and age. Once you are back in Ireland, the HSE’s October-to-early-March limit still applies, so a week away in stronger sun is not a reliable plan for the rest of the year. EFSA scientific opinion on variability in sun-derived vitamin D HSE vitamin D guidance for Ireland

The balanced approach is simple: use ordinary outdoor daylight when it is available, but do not chase deliberate overexposure; in Ireland, the HSE treats part of the year as too low in UV-B to rely on sunshine alone. HSE vitamin D guidance for Ireland

Which foods provide meaningful amounts of vitamin D?

Natural sources: the biggest gains usually come from fish

Irish HSE food-planning tables give the clearest practical numbers for common foods: trout provides about 10 µg per 100 g, mackerel 8.6 µg, salmon 8 µg, sardines 5 µg, tuna 3 µg, and one egg about 2 µg. HSE nutrition standards for food provision

EFSA describes fatty fish, fish liver, fish liver oils, liver, meat products and egg yolks as the main natural vitamin D sources in European diets, and notes that egg-yolk content can vary with hen feed or UV-B exposure. EFSA scientific opinion on dietary reference values for vitamin D Buckinghamshire NHS vitamin D guidance

Natural vitamin D and fortified vitamin D are different things

EFSA distinguishes vitamin D naturally present in foods from vitamin D added during fortification. In its review, vitamin D3 is the form naturally present in the main animal-food sources, while mushrooms and fungi exposed to UV-B provide vitamin D2. EFSA scientific opinion on dietary reference values for vitamin D

For fortified foods sold across Ireland and Europe, EFSA lists milk, dairy imitates such as plant drinks, margarines and similar spreads, breakfast cereals, cheeses, dairy desserts and fermented milk products as common categories. Irish HSE tables put fortified milk at about 4 µg per 200 mL, fortified yoghurt at 0.8–5 µg per 125 g, and fortified cereal at 1.5–2.9 µg per 30–40 g. EFSA fortified-food categories and composition data HSE nutrition standards for food provision

Why do labels vary? EFSA notes that fortification practices vary substantially between countries, and its category averages are broad: around 1 µg per 100 mL for milk and dairy imitates, 5.97 µg per 100 g for margarine-like spreads, 2.08 µg per 100 g for breakfast cereals and 2.10 µg per 100 g for cheese. That is why checking the nutrition panel on the exact product matters more than assuming all plant drinks, yogurts or cereals are fortified alike. EFSA nutrient composition data for fortified foods

UV-exposed mushrooms: useful, but not all mushrooms are the same

So the food name alone is not enough; the label or product details matter. EFSA scientific opinion on dietary reference values for vitamin D

Food can clearly contribute, but winter totals can still be modest. The HSE advises 15 µg a day for people aged 13–64 from Halloween to St Patrick’s Day, and says sunlight in Ireland is not strong enough to generate vitamin D in the skin between October and early March. Against that figure, a 100 g salmon portion at 8 µg plus 200 mL fortified milk at 4 µg still does not reach 15 µg. HSE vitamin D guidance for Ireland HSE food-source amounts

What benefits are proven, and which claims are uncertain?

Three different standards often get blurred together. In EU law, a general-function claim describes support for normal body functions and does not refer to disease prevention or treatment, and EFSA says such claims are authorised only after scientific assessment in its definition of a general-function claim. EFSA’s consumer overview adds that, as of 2023, more than 260 health claims had been approved in the EU, while more than 70% of evaluated claims had been rejected for lack of scientific evidence on EFSA’s health-claims page. That legal standard is narrower than supplement marketing, and different again from established deficiency diseases.

Where the evidence is strongest

EFSA’s vitamin D opinion puts the clearest ground under bone-related outcomes. It says vitamin D deficiency leads to impaired bone mineralisation because dietary calcium and phosphorus are absorbed less efficiently, and that the clinical symptoms are rickets in children and osteomalacia in adults in EFSA’s scientific opinion on vitamin D. The same opinion says a serum 25(OH)D concentration of 50 nmol/L is a suitable target value for all population groups when setting dietary reference values, and that concentrations below 50 nmol/L are linked with increased risk of adverse musculoskeletal health outcomes in the same opinion.

Firm evidence for deficiency and musculoskeletal health does not automatically turn every wider vitamin D headline into a proven benefit.

Fractures and falls: calcium changes the picture

The fracture story is more limited than many adverts suggest. The NIH Office of Dietary Supplements says that, in older adults, vitamin D plus calcium slightly increases bone strength, but whether it reduces falls or fractures remains unclear in its consumer fact sheet. A Cochrane review reached a sharper split: vitamin D alone is unlikely to prevent fractures, while vitamin D plus calcium slightly reduces hip and other fractures in post-menopausal women and older men in the Cochrane review abstract. A practical reading is that “bone health” and “fewer fractures” are not interchangeable, and calcium co-interventions matter in the evidence.

Claims that stay uncertain

Why low vitamin D does not prove cause

Low vitamin D status often travels with poor health, but that does not prove it caused the problem. EFSA notes that serum 25(OH)D reflects both skin synthesis and dietary intake, and that skin synthesis varies with latitude, season, clouds, time outdoors, sunscreen use, clothing, skin colour and age in its scientific opinion. That means observational studies can spot associations, while still leaving open whether vitamin D is the driver, a marker of other factors, or both. EFSA therefore judged the non-musculoskeletal evidence insufficient for setting vitamin D reference values in the same opinion.

How are vitamin D deficiency and low levels identified?

What deficiency can look like

EFSA describes vitamin D deficiency as impaired bone mineralisation caused by inefficient absorption of calcium and phosphorus, with the clinical picture appearing as rickets in children and osteomalacia in adults. In adults, the signs can be less dramatic than in children: diffuse pain in muscles and bone, muscle pain, muscle weakness and specific fractures are listed by EFSA, and a UK adult guideline adds bone pain and tenderness as a result of osteomalacia.

In children, EFSA describes rickets as a triad of skeletal changes such as deformities, craniotabes and growth retardation, radiologic changes, and raised serum alkaline phosphatase. That is why the same low-status problem can present very differently: a child may come to attention because of skeletal changes, while an adult may be investigated for chronic widespread pain or proximal muscle weakness suggestive of osteomalacia.

Why levels fall beyond low sun exposure

When skin synthesis is lacking or insufficient, dietary vitamin D becomes essential, so low intake matters most when sun-derived production is limited. Adult risk guidance also lists malabsorption, short bowel, untreated coeliac disease, cholestatic liver disease, and medicines such as anti-epileptics, rifampicin, glucocorticoids, antiretrovirals and cholestyramine among common reasons status can run low.

The conversion pathway also matters clinically. Vitamin D is hydroxylated in the liver to 25(OH)D and mainly in the kidney to its active form, and the same guideline flags severe liver disease and chronic kidney disease with eGFR below 30 mL/min as situations needing specialist advice before treatment.

The blood test and the units

The usual marker is plasma 25-hydroxyvitamin D, often written 25(OH)D; EFSA uses serum 25(OH)D as the biomarker of vitamin D status because it reflects vitamin D from both skin synthesis and diet. Labs may report it in nmol/L or ng/mL, and 2. 5 nmol/L equals 1 ng/mL, so comparing results without converting is a common mistake.

Those cut-offs differ because they are built for different jobs: EFSA’s 50 nmol/L is a population target used when setting dietary reference values under conditions of minimal sun exposure, while clinical pathways use action bands for who to test and how to follow up. EFSA also notes high variability between analytical methods, so tiny differences between results should not be over-read.

When testing is useful, and how confirmed deficiency is handled

Routine screening is usually not recommended. Asymptomatic people at higher risk do not need routine vitamin D testing, and vitamin D testing is not routinely required. Testing is reserved for situations such as suspected osteomalacia, chronic widespread pain with proximal muscle weakness, suspected bone disease, or before potent antiresorptive or anabolic treatment.

When low status is confirmed in that clinical setting, guidance uses a different pathway from ordinary maintenance use. For symptomatic disease or before certain bone medicines, Buckinghamshire describes a loading course totalling about 280,000-300,000 IU followed by 800-2,000 IU daily equivalent maintenance; routine repeat testing is generally unnecessary, but may be considered after 3-6 months when symptoms persist, malabsorption is present or adherence is uncertain. By contrast, everyday maintenance for adults at risk is described as 400 IU (10 micrograms) daily year-round.

How do you choose and use a vitamin D supplement?

Match the label to HSE advice, not to the biggest number

The first check is the daily serving on the label, then the units. The HSE’s routine advice is age- and season-specific: 15 micrograms a day for people aged 13 to 64 from Halloween to St Patrick’s Day, and 15 micrograms all year for adults 65+; 5 micrograms a day for children aged 1 to 4 in winter; and 5 micrograms a day for breastfed babies under 12 months, or babies taking less than 300 ml of formula a day. EFSA notes that 1 microgram equals 40 IU, so 10 micrograms is 400 IU and 15 micrograms is 600 IU.

More is not automatically better. The HSE lists upper limits of 25 micrograms a day for babies under 12 months, 50 micrograms for children aged 1 to 10, and 100 micrograms for adults and children aged 11+. A “high strength” product can therefore be far above routine HSE advice, even if it still sits below the adult upper limit.

D2, D3 and vegan options

EFSA defines vitamin D as ergocalciferol (D2) and cholecalciferol (D3), and says both forms are present in foods and supplements. NHS Specialist Pharmacy Service says there is some evidence that colecalciferol is more effective than ergocalciferol, which is why D3 is preferred where possible. The same source notes that D3 can come from lanolin or lichen, while D2 is produced from fungi or yeasts. Vegan shoppers should also check the rest of the formula, because gelatin and other animal-derived excipients can appear in capsules and tablets.

Format matters less than dose, form and routine

Whether the supplement is a tablet, capsule, spray or drops, compare the same basics: vitamin form, micrograms or IU per daily dose, and how many doses you actually need. EFSA says vitamin D is fat-soluble and that data on the effect of the food or supplement matrix are limited, so flashy claims for one format over another deserve caution.

Choose the dose that fits HSE advice, then take it consistently enough that you do not forget it.

A simple daily habit is usually the most practical. UK NHS prescribing guidance uses daily maintenance doses such as 1,000 IU, or an intermittent higher equivalent dose. The same kind of intermittent approach belongs under clinical guidance when doses become large: Buckinghamshire NHS guidance uses about 300,000 IU over 6 to 10 weeks for loading regimens, and says 60,000 IU monthly should be avoided. Common buying mistakes are simple: mixing up micrograms with IU, forgetting that multivitamins and cod liver oil can also contain vitamin D, and assuming “high strength” means “right for me. ”

Who needs extra caution with vitamin D supplements?

Upper limits are safety ceilings, not routine targets

The numbers used for routine supplementation are much lower than the numbers used for safety ceilings. In Ireland, the HSE advises 5 µg/day for specified babies under 12 months, 5 µg/day for children aged 1–4 during Halloween-to-St Patrick’s Day, 10 µg/day for children aged 5–12 across winter, 15 µg/day for people aged 13–64 across winter, and 15 µg/day all year for adults aged 65+. By contrast, EFSA defines a tolerable upper intake level as the maximum average daily intake unlikely to pose a risk of adverse effects.

How toxicity happens, and the symptoms to recognise

EFSA says vitamin D toxicity results from long-term ingestion of large doses. The practical complication readers need to recognise is hypercalcaemia: too much calcium in the blood. NIH lists nausea, vomiting, muscle weakness, confusion, dehydration, excessive thirst or urination, and kidney stones among the warning signs; in extreme cases it can progress to kidney failure, soft-tissue calcification, irregular heart rhythm and death. In infants, EFSA focused on hypercalciuria, hypercalcaemia and nephrocalcinosis when assessing excess intake.

Medicines and medical conditions that change the risk

Several medicines can complicate vitamin D use. NIH says orlistat can reduce absorption of vitamin D, corticosteroids can lower vitamin D levels, and thiazide diuretics taken with vitamin D can raise blood calcium too much, especially in older adults and people with compromised kidney function.

After accidental overuse

Evidence on toxicity points to chronic high intake rather than ordinary food intake, but symptoms should not be brushed off. NIH’s list of nausea, vomiting, confusion, dehydration, excessive thirst or urination, muscle weakness, or kidney-stone symptoms is the point at which medical review matters more than home guesswork.